Page last updated: 2024-10-19

phenylacetic acid and Glioblastoma with Sarcomatous Component

phenylacetic acid has been researched along with Glioblastoma with Sarcomatous Component in 1 studies

phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.

Research Excerpts

ExcerptRelevanceReference
"Rats with established brain tumors (n = 12) received continuous s."1.29Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate. ( Myers, CE; Oldfield, EH; Oshiro, EM; Ram, Z; Samid, D; Shack, S; Tao-Cheng, JH; Thibault, A; Viola, JJ; Walbridge, S, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ram, Z1
Samid, D1
Walbridge, S1
Oshiro, EM1
Viola, JJ1
Tao-Cheng, JH1
Shack, S1
Thibault, A1
Myers, CE1
Oldfield, EH1

Other Studies

1 other study available for phenylacetic acid and Glioblastoma with Sarcomatous Component

ArticleYear
Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate.
    Cancer research, 1994, Jun-01, Volume: 54, Issue:11

    Topics: Animals; Brain Neoplasms; Cell Division; Drug Screening Assays, Antitumor; Gliosarcoma; Microscopy,

1994